Mangoceuticals, Inc.
Nasdaq · Healthcare · Services-Misc Health & Allied Services, Nec · Dallas, TX
MGRX chart
What traders are saying about $MGRX
Latest postsMangoceuticals, Inc. news
- Mangoceuticals, Inc. (MGRX) Seasonal returns chart
Yahoo Finance UK ·
- Form 8K Mangoceuticals Inc For: 6 November By Investing.com
Investing.com Nigeria ·
- Form PRE 14A Mangoceuticals For: 6 November By Investing.com
Investing.com Nigeria ·
- Mangoceuticals Clears Path for $10M Series D Preferred Offering
Minichart ·
- Mangoceuticals board and preferred shareholder approve new Series D preferred stock
Investing.com ·
- Mangoceuticals Announces Combined 2025-2026 Annual Meeting for December 30, 2026
Kalkine Media ·
- Mangoceuticals Sets Combined 2025 and 2026 Shareholder Meeting
TipRanks ·
- Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Yahoo Finance ·
- Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
Yahoo Finance ·
- Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
Yahoo Finance ·
- Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
Yahoo Finance ·
- Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor
Yahoo Finance ·
Mangoceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $456,021 | $615,873 | $731,493 | $8,939 |
| Net income | -$20.6M | -$8.7M | -$9.2M | -$2.0M |
| Diluted EPS | $-2.17 | $-4.80 | $-8.58 | $-0.19 |
| Total assets (year end) | $16.1M | $15.4M | $1.1M | $1.0M |
| Cash and equivalents (year end) | $1.5M | $58,653 | $739,006 | $682,860 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Mangoceuticals, Inc.
- Ticker
- MGRX (Nasdaq)
- Industry
- Services-Misc Health & Allied Services, Nec
- Headquarters
- Dallas, TX
- Incorporated in
- TX
- Fiscal year end
- December 31
- SEC CIK
- 1938046
- Former names
- MANGOCEUTICALS, INC.
Frequently asked questions
What exchange is Mangoceuticals, Inc. listed on?
Mangoceuticals, Inc. trades on the Nasdaq under the ticker symbol MGRX.
What industry is Mangoceuticals, Inc. in?
Mangoceuticals, Inc. is classified by the SEC under "Services-Misc Health & Allied Services, Nec", part of the Healthcare sector on StockTweeting.
Where is Mangoceuticals, Inc. headquartered?
Mangoceuticals, Inc.'s business address on file with the SEC is in Dallas, TX.
When does Mangoceuticals, Inc.'s fiscal year end?
Mangoceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Mangoceuticals, Inc. report?
Mangoceuticals, Inc. reported $456,021 in revenue for calendar year 2025, according to its SEC filings.